David Weill - 22 May 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
22 May 2025
Transactions value $
-$90,680
Form type
4
Filing time
23 May 2025, 18:41:03 UTC
Previous filing
31 May 2024
Next filing
05 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weill David Director C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER By: /s/ Gerardo Hernandez, Attorney-in-Fact 23 May 2025 0001774270

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +2.13K +19.88% $0.00 12.9K 22 May 2025 Direct F1
transaction TMDX Common Stock Sale -$90.7K -732 -5.69% $123.88 12.1K 23 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.